RIP medical device pioneer Alfred Mann | Personnel Moves

February 26, 2016 By Brad Perriello Leave a Comment

Alfred Mann, a medical device entrepreneur who helped develop several groundbreaking technologies, died yesterday at age 90, shortly after stepping down from a pair of companies he founded.

Mann founded 17 companies over his 70-year career, in industries ranging from aerospace to medtech, according to the L.A. Times.

After Johns Hopkins University researchers in 1969 asked him to help create a longer-lasting pacemaker, Mann turned his eye from the aerospace industry to medtech, according to the Times. In later years he founded several medical device companies, including MiniMed, which Medtronic (NYSE:MDT) acquired for $3.3 billion in 2001.

Mann also started Advanced Bionics, which helped pioneer the cochlear implant; Second Sight Medical (NSDQ:EYES) and its retinal implant for treating blindness; and pharmaceutical company MannKind (NSDQ: MNKD), which is working on an inhalable insulin product. In recent weeks he stepped down from his roles at Second Sight and MannKind, the newspaper reported.

“We are all deeply saddened by the loss of our founder, mentor and friend, Al Mann, a pioneering leader whose contributions and vision profoundly impacted the lives of so many and whose legacy will impact many more. Everyone he came in contact with was enriched and inspired by him. Personally, I am eternally grateful for Al’s generous guidance and support these last 16 years. At Second Sight, we all feel deeply honored to have worked alongside of and known such a remarkable person. The world is a little darker without his presence, but his spirit will live on in every blind person who is brought back into the light by our products,” Second Sight co-founder & chairman Dr. Robert Greenberg said in prepared remarks.

“Al has been a wonderful inspiration, not only to me, but to all the employees of MannKind. His kindness, generosity, and business acumen have influenced all of us with whom he has done business and charitable work over the years. He will be terribly missed by many, including the countless patients around the world with diabetes and other serious illnesses, whose lives he improved. I am thankful to have had a close relationship with Al, and will reflect on his counsel and guidance in the years to come. Our resolve is now stronger than ever to continue Al’s legacy of medical innovation, as a tribute to this remarkable man, who did so much to help mankind,” added MannKind CEO Matthew Pfeffer.

New Corindus Vascular Robotics CEO is Boston Scientific vet Toland
Corindus Vascular Robotics (OTC:CVRS) tapped former Boston Scientific (NYSE:BSX) SVP Mark Toland to be its new CEO, replacing David Handler in the corner office.
Read more

Valeritas shakes things up, promoting COO Timberlake to CEO, adding to board
Insulin pump developer Valeritas shook things up yesterday, announcing the retirement of CEO Kris Peterson and promoting president & COO John Timberlake to chief executive spot and naming him to its board of directors. Valeritas also added a trio from private equity shop CRG to its board: Managing director Luke Duster, president Nate Hukill and associate Cameron Hui.
Read more

Hansen Medical loses biz dev SVP Guido
Hansen Medical (NSDQ:HNSN) said Feb. 24 that marketing & business development senior VP Joe Guido resigned effective Feb. 19. The company said it has no plans to replace Guido, as his responsibilities will be assumed by other managers.
Read more

LifeImage elevates Phillips to SVP
LifeImage said it elevated longtime employee Jim Phillips to be its senior vice president of client services.
Read more

Certain GE Healthcare patient-monitoring devices vulnerable to cyberattack
The federal government and GE Healthcare (NYSE:GE) announced today that the certain of the company’s patient monitoring devices are vulnerable to cyberattack. If attacked, some versions of the Carescape and ApexPro telemetry servers, the Carescape Central Station version 1 and Central Information Center systems could stop monitoring patients, silence alarms or produce unnecessary alarms during… […]
Cardinal Health recalls 9 million surgical gowns, sends hospitals scrambling
Cardinal Health (NYSE:CAH) announced that it is voluntarily recalling 9.1 million surgical gowns produced by an unnamed contract manufacturer after discovering quality issues with the product. The Dublin, Ohio-based company said that some gowns were produced in unapproved locations that did not maintain proper environmental conditions as required by law. Some of the gowns were also… […]
KNF launches compact swing piston pump
KNF Neuberger is touting its NPK 06 swing piston micro gas pumps, designed to deliver high-flow and high-pressure performance in a compact size. The new pumps work well for medical diagnostics, therapy, monitoring, and general compression applications, according to the Trenton, N.J.-based company. NPK 06 measures 1.85” (47mm) wide and can produce free flow up… […]
Heraeus Medical Components and Myant partner on electrical sensing for textiles
Heraeus Medical Components (St. Paul, Minn.) and Toronto-based Myant have entered a partnership enabling Myant to use Heraeus’ Tectitoat for electrical sensing applications in textiles, the companies announced today. Tecticoat is a conductive polymer-based coating that can be applied to textiles to control electrical conductivity, electromagnetic shielding and electrostatic dissipation, making it suitable for integration… […]
Cook Medical’s peripheral artery set debuts in U.S.
Cook Medical recently announced the U.S. launch of its TriForce peripheral crossing set to support vascular obstruction procedures. The TriForce set is designed to be percutaneously introduced into blood vessels to support a wire guide while performing a peripheral intervention, according to the Bloomington, Ind.-based company. This device is also intended for injection of radiopaque… […]
Bayer and Exscientia partner to bring AI to drug discovery
Bayer (ETR:BAYN) announced that it is entering into a collaboration agreement with artificial intelligence drug discovery company Exscientia to identify and optimize novel lead structures for potential drug candidates in treating cardiovascular and oncological diseases. The agreement, announced earlier this month, is slated to see the companies work together on early research projects combining Exscientia’s proprietary… […]
GHO Capital acquires Ardena
European specialist investor Global Healthcare Opportunities, also called GHO Capital Partners, recently announced that it has acquired Ardena — a specialist contract development and manufacturing organization focused on early phase drug development. Financial terms of the deal, announced Jan. 9, were not disclosed. Get the full story on sister site Drug Discovery and Development. The […]
Albright Silicone launches 3D printed tooling for silicone molding
Albright Silicone (Leominster, Mass.) recently announced that it has added 3D printed tooling for LSR molding, touting the relative low coast and rapid turnaround the process offers for prototyping. “This capability of 3D printing and molding LSR is a helpful solution to customers’ problems when trying to develop and prove a concept before investing in… […]
BREAKING: Medtronic wins FDA approval for Micra AV
Medtronic (NYSE:MDT) has won FDA approval for its Micra AV — greatly expanding the number of people who could potentially benefit from leadless pacemaker technology. The medical device giant plans to start offering the Micra AV in a limited number of implanting centers in the coming weeks, with a full launch expected in the spring. FDA… […]
FDA reclassifies some medical image analyzers
The FDA today imposed stricter regulations on certain radiological medical image analyzers, reclassifying them from Class III to Class II. Affected products include computer-assisted detection (CADe) devices for breast cancer mammography, breast-lesion ultrasound, and lung-nodule and dental-caries radiography, the agency said. It defines these devices as those intended to identify, mark, highlight, or in any… […]
Medline Industries temporarily halts EtO sterilization at Illinois plant
This article has been updated with a comment from Medela. Medline Industries has temporarily closed its Waukegan, Ill., medical device sterilization operation to install nearly $10 million in emissions upgrades. The privately owned company uses the carcinogenic gas ethylene oxide (EtO) to sterilize its own and other companies’ devices at the plant. Medline did not… […]